ES8106302A1 - Un procedimiento para la preparacion de derivados de acido trans-(4-oxo-4h-quinazolin-3-il)-2-propenoico - Google Patents

Un procedimiento para la preparacion de derivados de acido trans-(4-oxo-4h-quinazolin-3-il)-2-propenoico

Info

Publication number
ES8106302A1
ES8106302A1 ES493203A ES493203A ES8106302A1 ES 8106302 A1 ES8106302 A1 ES 8106302A1 ES 493203 A ES493203 A ES 493203A ES 493203 A ES493203 A ES 493203A ES 8106302 A1 ES8106302 A1 ES 8106302A1
Authority
ES
Spain
Prior art keywords
derivatives
formula
trans
intermediates
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES493203A
Other languages
English (en)
Spanish (es)
Other versions
ES493203A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES493203A0 publication Critical patent/ES493203A0/es
Publication of ES8106302A1 publication Critical patent/ES8106302A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES493203A 1979-07-09 1980-07-08 Un procedimiento para la preparacion de derivados de acido trans-(4-oxo-4h-quinazolin-3-il)-2-propenoico Expired ES8106302A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5572879A 1979-07-09 1979-07-09
US06/142,903 US4281127A (en) 1979-07-09 1980-04-23 Trans-3-(4-oxo-4H-quinazolin-3-yl)-2-propenoic acid derivatives

Publications (2)

Publication Number Publication Date
ES493203A0 ES493203A0 (es) 1981-05-16
ES8106302A1 true ES8106302A1 (es) 1981-05-16

Family

ID=26734565

Family Applications (2)

Application Number Title Priority Date Filing Date
ES493203A Expired ES8106302A1 (es) 1979-07-09 1980-07-08 Un procedimiento para la preparacion de derivados de acido trans-(4-oxo-4h-quinazolin-3-il)-2-propenoico
ES499035A Granted ES499035A0 (es) 1979-07-09 1981-02-02 Un procedimiento para la preparacion de derivados de acido trans-(4-oxo-4h-quinazolin-3-il)-2-propenoico

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES499035A Granted ES499035A0 (es) 1979-07-09 1981-02-02 Un procedimiento para la preparacion de derivados de acido trans-(4-oxo-4h-quinazolin-3-il)-2-propenoico

Country Status (21)

Country Link
US (1) US4281127A (enExample)
EP (1) EP0023594B1 (enExample)
AR (1) AR226854A1 (enExample)
AU (1) AU521014B2 (enExample)
CA (1) CA1134825A (enExample)
DE (1) DE3067830D1 (enExample)
DK (1) DK150483C (enExample)
ES (2) ES8106302A1 (enExample)
FI (1) FI74279C (enExample)
GR (1) GR65952B (enExample)
HK (1) HK52187A (enExample)
HU (1) HU184797B (enExample)
IE (1) IE49938B1 (enExample)
IL (1) IL60514A (enExample)
MC (1) MC1333A1 (enExample)
NO (1) NO154426C (enExample)
NZ (1) NZ194259A (enExample)
PH (1) PH16413A (enExample)
PT (1) PT71512B (enExample)
SG (1) SG20887G (enExample)
YU (1) YU42348B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599336A (en) * 1983-08-08 1986-07-08 Hoffmann-La Roche Inc. Derivatives of (E)-3-(4-oxo-4H-quinazolin-3-yl)-2-propenamide
GB9404485D0 (en) * 1994-03-09 1994-04-20 Cancer Res Campaign Tech Benzamide analogues
US6706721B1 (en) * 1998-04-29 2004-03-16 Osi Pharmaceuticals, Inc. N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate
US6545004B1 (en) * 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
US7230000B1 (en) 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
UA74803C2 (uk) 1999-11-11 2006-02-15 Осі Фармасьютікалз, Інк. Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
US7087613B2 (en) * 1999-11-11 2006-08-08 Osi Pharmaceuticals, Inc. Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
WO2003070701A2 (en) * 2002-02-15 2003-08-28 Cytokinetics, Inc. Syntheses of quinazolinones
AU2003270015A1 (en) 2002-05-09 2003-12-02 Cytokinetics, Inc. Compounds, compositions, and methods
WO2003094839A2 (en) * 2002-05-09 2003-11-20 Cytokinetics, Inc. Pyrimidinone compounds, compositions and methods
JP2005536475A (ja) * 2002-05-23 2005-12-02 サイトキネティクス・インコーポレーテッド 化合物、組成物、および方法
EP1556357A4 (en) * 2002-06-14 2006-09-13 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
EP1537089A4 (en) * 2002-07-23 2008-04-16 Cytokinetics Inc CONNECTIONS, COMPOSITIONS AND PROCEDURES
AU2003262747A1 (en) * 2002-08-21 2004-03-11 Cytokinetics, Inc. Compounds, compositions, and methods
EP1558083A4 (en) * 2002-09-30 2008-04-16 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
WO2005041888A2 (en) * 2003-11-03 2005-05-12 Cytokinetics, Inc. Pyrimidin-4-one compounds, compositions and methods
US20050148593A1 (en) * 2003-11-07 2005-07-07 Gustave Bergnes Compounds, compositions, and methods
JP2007513154A (ja) * 2003-12-08 2007-05-24 サイトキネティクス・インコーポレーテッド 化合物、組成物及び方法
UY29198A1 (es) * 2004-11-09 2006-05-31 Cancer Rec Tech Ltd Derivados sustituidos de quinazolinona y derivados sustituidos de quinazolina-2, 4-diona, composiciones conteniéndolos, procedimientos de preparación y aplicaciones

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2786055A (en) * 1955-02-10 1957-03-19 Mallinckrodt Chemical Works Carboxyalkyl-iodoquinazolones
US3517005A (en) * 1967-10-26 1970-06-23 Pfizer & Co C Certain 2- and 4-substituted quinazolines
US3696102A (en) * 1970-03-09 1972-10-03 Pfizer & Co C Process for the synthesis of substituted quinazolin-4-ones

Also Published As

Publication number Publication date
FI74279B (fi) 1987-09-30
ES8207155A1 (es) 1982-09-16
DK150483B (da) 1987-03-09
GR65952B (enExample) 1981-01-09
NO154426B (no) 1986-06-09
DK150483C (da) 1987-11-09
DE3067830D1 (en) 1984-06-20
FI74279C (fi) 1988-01-11
NZ194259A (en) 1984-09-28
HK52187A (en) 1987-07-17
EP0023594B1 (de) 1984-05-16
ES493203A0 (es) 1981-05-16
AU6024480A (en) 1981-03-12
YU176680A (en) 1984-12-31
PT71512A (en) 1980-08-01
FI802195A7 (fi) 1981-01-10
NO802056L (no) 1981-01-12
US4281127A (en) 1981-07-28
EP0023594A1 (de) 1981-02-11
MC1333A1 (fr) 1981-04-21
IE49938B1 (en) 1986-01-08
IL60514A0 (en) 1980-09-16
NO154426C (no) 1986-09-17
AU521014B2 (en) 1982-03-11
ES499035A0 (es) 1982-09-16
IL60514A (en) 1985-03-31
IE801412L (en) 1981-01-09
HU184797B (en) 1984-10-29
CA1134825A (en) 1982-11-02
PT71512B (en) 1981-12-11
AR226854A1 (es) 1982-08-31
DK294780A (da) 1981-01-10
YU42348B (en) 1988-08-31
PH16413A (en) 1983-09-29
SG20887G (en) 1988-09-16

Similar Documents

Publication Publication Date Title
ES8106302A1 (es) Un procedimiento para la preparacion de derivados de acido trans-(4-oxo-4h-quinazolin-3-il)-2-propenoico
ES8207136A1 (es) Procedimiento para preparar derivados de guanidina
ES8306110A1 (es) "procedimiento para la preparacion de derivados de urea".
ES8306119A1 (es) Procedimiento para la obtencion de derivados de imidazol trisustituidos.
CL2003002665A1 (es) COMPUESTOS DERIVADOS DE ACIDOS CARBOXILICOS, SUS SALES; PROCEDIMIENTO DE PREPARACION; COMPOSICION FARMACEUTICA, Y SU USO EN EL TRATAMIENTO DE ENFERMEDADES DONDE ES NECESARIO UN INHIBIDORE DEL FACTOR Xa Y /O UN INHIBIDOR DE SERINA PROTEASA.
ES8404330A1 (es) Un metodo para la produccion de derivados de esteres de acidos 1,4-dihidropiridin-3,5-dicarboxilicos.
ES8801222A1 (es) Un procedimiento para la preparacion de nuevos derivados de ciclopenta(d)pirimidina
ES8609193A1 (es) Procedimiento para preparar analogos de mevalonolactona y derivados de los mismos
ES8507498A1 (es) Un procedimiento para la preparacion de acidos fenilquinolin-carboxilicos.
ES8706608A1 (es) Un procedimiento para preparar derivados de arilciclobutilalquilamina
ES8102137A1 (es) Procedimiento para la obtencion de vinil-3 cefalosporinas
ES8608502A1 (es) Procedimiento para la obtencion de benzofuranonas
ES8606362A1 (es) "un procedimiento para preparar un derivado de cefem".
ES8306181A1 (es) "un procedimiento para preparar insulina humana o derivados de treomina b30 de insulina humana".
ES8607295A1 (es) Derivados de b-lactama
ES8305345A1 (es) "procedimiento para la preparacion de nuevos derivados de acidos 2-amino-carboxilicos".
ES8800671A1 (es) Procedimiento para preparar 5-pirimidin-carboxamidas sustituidas con actividad anti-leucemia
GB1033777A (en) Bis-anilide derivatives
ES8403461A1 (es) Procedimiento de preparacion de derivados de imidazolidina.
ES2010736A6 (es) Procedimiento para preparar nuevos derivados del acido furanuronico.
ES470916A1 (es) Ÿun procedimiento para la preparacion de derivados de acidos4-hidroxi-2-quinolinon-3-carboxilicosŸ
ES8206470A1 (es) Procedimiento para la preparacion de nuevas indolinonas.
ES8604861A1 (es) Procedimiento para la preparacion de derivados de fenilace- tonitrilo
ES8602002A1 (es) Procedimiento para preparar nuevas 4-fenil-tetrahidrofurano-(2,3-c)priridinas
ES8607922A1 (es) Procedimiento para preparar 9-oxo-15 a-hidroxi-16-fenoxi y 16-fenoxi sustituido-17,18,19,20-tetranorprosta-4,5,13 (e)- trienoatos

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970203